title: Increasing insulin dose for olanzapine-related diabetes.
authors.forename: Richard P
authors.initials: RP
authors.lastname: Johnson
authors.forename: Mohammed T
authors.initials: MT
authors.lastname: Al-Taher
authors.forename: Lawrence E
authors.initials: LE
authors.lastname: Madlock
authors.forename: Mei
authors.initials: M
authors.lastname: Guo
authors.forename: Clifford S
authors.initials: CS
authors.lastname: Nasdahl
mesh_terms: D001569:Benzodiazepines; D001786:Blood Glucose / Q000378:metabolism; D015992:Body Mass Index; D016883:Diabetic Ketoacidosis / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006801:Humans; D007328:Insulin / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012016:Reference Values; D012559:Schizophrenia / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D001786:Blood Glucose; D007328:Insulin; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine